Obstructive Sleep Apnoea Syndrome: Continuous Positive Airway Pressure Therapy for Prevention of Cardiovascular Risk

Obstructive sleep apnoea (OSA) syndrome is characterised by the presence of apnoea or obstructive hypopnoea during sleep, accompanied by hypoxia. It is estimated that the syndrome affects approximately 10% of men and 15% of women. Diagnosis and treatment rates have increased in recent years, but the...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	María Pilar Resano-Barrio, Ramón Arroyo-Espliguero, María Carmen Viana-Llamas, Olga Mediano
Formato:	article
Lenguaje:	EN
Publicado:	Radcliffe Medical Media 2020
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/53d93c7f48fd46cda42e866a214ed627
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:53d93c7f48fd46cda42e866a214ed627
record_format	dspace
spelling	oai:doaj.org-article:53d93c7f48fd46cda42e866a214ed6272021-12-04T16:03:37ZObstructive Sleep Apnoea Syndrome: Continuous Positive Airway Pressure Therapy for Prevention of Cardiovascular Risk10.15420/ecr.2020.101758-37641758-3756https://doaj.org/article/53d93c7f48fd46cda42e866a214ed6272020-09-01T00:00:00Zhttps://www.ecrjournal.com/articles/obstructive-sleep-apnoea-syndromehttps://doaj.org/toc/1758-3756https://doaj.org/toc/1758-3764Obstructive sleep apnoea (OSA) syndrome is characterised by the presence of apnoea or obstructive hypopnoea during sleep, accompanied by hypoxia. It is estimated that the syndrome affects approximately 10% of men and 15% of women. Diagnosis and treatment rates have increased in recent years, but the condition remains undiagnosed in a high percentage of patients. Recent evidence suggests that OSA may increase the risk of cardiovascular disease. The relationship between OSA and cardiovascular disease can be explained, at least in part, by the coexistence of cardiovascular risk factors in the two pathologies, such as age, overweight, smoking and sedentary lifestyle. However, OSA has been independently associated with the risk of developing hypertension, cerebrovascular disease, ischaemic heart disease, heart failure and arrhythmias. Clinical trials that have evaluated the efficacy of continuous positive airway pressure (CPAP) treatment in primary and secondary cardiovascular prevention have not demonstrated a significant reduction in the incidence or recurrence of cardiovascular events. This article analyses the relationship between OSA and cardiovascular risk and discusses recent clinical trials on the efficacy of CPAP in primary and secondary cardiovascular prevention.María Pilar Resano-BarrioRamón Arroyo-EspligueroMaría Carmen Viana-LlamasOlga MedianoRadcliffe Medical MediaarticleDiseases of the circulatory (Cardiovascular) systemRC666-701ENEuropean Cardiology Review , Vol 15, Iss , Pp - (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	Diseases of the circulatory (Cardiovascular) system RC666-701
spellingShingle	Diseases of the circulatory (Cardiovascular) system RC666-701 María Pilar Resano-Barrio Ramón Arroyo-Espliguero María Carmen Viana-Llamas Olga Mediano Obstructive Sleep Apnoea Syndrome: Continuous Positive Airway Pressure Therapy for Prevention of Cardiovascular Risk
description	Obstructive sleep apnoea (OSA) syndrome is characterised by the presence of apnoea or obstructive hypopnoea during sleep, accompanied by hypoxia. It is estimated that the syndrome affects approximately 10% of men and 15% of women. Diagnosis and treatment rates have increased in recent years, but the condition remains undiagnosed in a high percentage of patients. Recent evidence suggests that OSA may increase the risk of cardiovascular disease. The relationship between OSA and cardiovascular disease can be explained, at least in part, by the coexistence of cardiovascular risk factors in the two pathologies, such as age, overweight, smoking and sedentary lifestyle. However, OSA has been independently associated with the risk of developing hypertension, cerebrovascular disease, ischaemic heart disease, heart failure and arrhythmias. Clinical trials that have evaluated the efficacy of continuous positive airway pressure (CPAP) treatment in primary and secondary cardiovascular prevention have not demonstrated a significant reduction in the incidence or recurrence of cardiovascular events. This article analyses the relationship between OSA and cardiovascular risk and discusses recent clinical trials on the efficacy of CPAP in primary and secondary cardiovascular prevention.
format	article
author	María Pilar Resano-Barrio Ramón Arroyo-Espliguero María Carmen Viana-Llamas Olga Mediano
author_facet	María Pilar Resano-Barrio Ramón Arroyo-Espliguero María Carmen Viana-Llamas Olga Mediano
author_sort	María Pilar Resano-Barrio
title	Obstructive Sleep Apnoea Syndrome: Continuous Positive Airway Pressure Therapy for Prevention of Cardiovascular Risk
title_short	Obstructive Sleep Apnoea Syndrome: Continuous Positive Airway Pressure Therapy for Prevention of Cardiovascular Risk
title_full	Obstructive Sleep Apnoea Syndrome: Continuous Positive Airway Pressure Therapy for Prevention of Cardiovascular Risk
title_fullStr	Obstructive Sleep Apnoea Syndrome: Continuous Positive Airway Pressure Therapy for Prevention of Cardiovascular Risk
title_full_unstemmed	Obstructive Sleep Apnoea Syndrome: Continuous Positive Airway Pressure Therapy for Prevention of Cardiovascular Risk
title_sort	obstructive sleep apnoea syndrome: continuous positive airway pressure therapy for prevention of cardiovascular risk
publisher	Radcliffe Medical Media
publishDate	2020
url	https://doaj.org/article/53d93c7f48fd46cda42e866a214ed627
work_keys_str_mv	AT mariapilarresanobarrio obstructivesleepapnoeasyndromecontinuouspositiveairwaypressuretherapyforpreventionofcardiovascularrisk AT ramonarroyoespliguero obstructivesleepapnoeasyndromecontinuouspositiveairwaypressuretherapyforpreventionofcardiovascularrisk AT mariacarmenvianallamas obstructivesleepapnoeasyndromecontinuouspositiveairwaypressuretherapyforpreventionofcardiovascularrisk AT olgamediano obstructivesleepapnoeasyndromecontinuouspositiveairwaypressuretherapyforpreventionofcardiovascularrisk
_version_	1718372734483824640

Obstructive Sleep Apnoea Syndrome: Continuous Positive Airway Pressure Therapy for Prevention of Cardiovascular Risk

Ejemplares similares